BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 347933)

  • 1. Terminal deoxynucleotidyl transferase in the diagnosis of leukemia and malignant lymphoma.
    Kung PC; Long JC; McCaffrey RP; Ratliff RL; Harrison TA; Baltimore D
    Am J Med; 1978 May; 64(5):788-94. PubMed ID: 347933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Terminal deoxynucleotidyl transferase, TdT, as a marker for leukemia and lymphoma cells.
    Campagnari F; Bombardieri E; de Braud F; Baldini L; Maiolo AT
    Int J Biol Markers; 1987; 2(1):31-42. PubMed ID: 3323341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of TdT positivity in cases of leukemia and lymphoma.
    Drexler HG; Menon M; Minowada J
    Acta Haematol; 1986; 75(1):12-7. PubMed ID: 3088880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of the enzyme terminal deoxyribonucleotidyl transferase in lymphoma and leukemia cells].
    Bombardieri E; Campagnari F; De Braud F; Clerici L; Maiolo AT; Villa ML; Cappelletti V; Saccani Jotti G; Vezzoni P; Neri A
    Acta Biomed Ateneo Parmense; 1984; 55(1):15-23. PubMed ID: 6232800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Terminal deoxynucleotidyl transferase activity in lymphoma.
    Habeshaw JA; Catley PF; Stansfield AG; Ganeshaguru K; Hoffbrand AV
    Br J Cancer; 1979 May; 39(5):566-9. PubMed ID: 314814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 013 (CD99) positivity in hematologic proliferations correlates with TdT positivity.
    Robertson PB; Neiman RS; Worapongpaiboon S; John K; Orazi A
    Mod Pathol; 1997 Apr; 10(4):277-82. PubMed ID: 9110287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic significance of terminal deoxynucleotidyl transferase (TDT) in patients with leukemias and malignant lymphomas.
    Mertelsmann R
    Adv Exp Med Biol; 1982; 145():259-77. PubMed ID: 7051779
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies of terminal deoxynucleotidyl transferase in normal and neoplastic human cells.
    Campagnari F; Clerici L; Bombardieri E; Vezzoni P; Di Fronzo G; Villa ML; Buraggi GL
    Adv Exp Med Biol; 1982; 145():305-20. PubMed ID: 6810661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Terminal deoxynucleotidyl transferase positive lymphoblastic lymphoma: a study of 15 cases.
    Long JC; McCaffrey RP; Aisenberg AC; Marks SM; Kung PC
    Cancer; 1979 Dec; 44(6):2127-39. PubMed ID: 315816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Terminal deoxynucleotidyl transferase staining of malignant lymphomas in paraffin sections.
    Orazi A; Cattoretti G; John K; Neiman RS
    Mod Pathol; 1994 Jun; 7(5):582-6. PubMed ID: 7937725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-cell immunofluorescence assay for terminal transferase: human leukaemic and non-leukaemic cells.
    Okamura S; Crane F; Jamal N; Messner HA; Mak TW
    Br J Cancer; 1980 Feb; 41(2):159-67. PubMed ID: 6989382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloblastic and lymphoblastic markers in acute undifferentiated leukemia and chronic myelogenous leukemia in blast crisis.
    Shumak KH; Baker MA; Taub RN; Coleman MS
    Cancer Res; 1980 Nov; 40(11):4048-52. PubMed ID: 6937237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical utility of leukemia cell terminal transferase measurements.
    McCaffrey R; Lillquist A; Sallan S; Cohen E; Osband M
    Cancer Res; 1981 Nov; 41(11 Pt 2):4814-20. PubMed ID: 7028251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Terminal deoxynucleotidyl transferase in non-Hodgkin's lymphoma.
    Braziel RM; Keneklis T; Donlon JA; Hsu SM; Cossman J; Bollum FJ; Jaffe ES
    Am J Clin Pathol; 1983 Nov; 80(5):655-9. PubMed ID: 6356870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Terminal deoxynucleotidyl transferase (TdT) and membrane receptors in human leukemia and lymphoma -- first experience with lyophilized cells.
    Wetter O; Hossfeld DK; Linder KH; Brandhorst D
    Klin Wochenschr; 1981 Apr; 59(8):365-75. PubMed ID: 6945460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enrichment of terminal deoxynucleotidyl transferase activity by cell separation.
    Sarin PS; Virmani M; Gallo RC
    Adv Exp Med Biol; 1982; 145():337-56. PubMed ID: 6981292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Terminal deoxynucleotidyl transferase as a hematopoietic cell marker.
    Bollum FJ
    Blood; 1979 Dec; 54(6):1203-15. PubMed ID: 389309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Terminal deoxynucleotidyl transferase activity in non-hematologic and hematologic neoplasms.
    Castella A; Davey FR; Kurec AS; Thompson NA
    Ann Clin Lab Sci; 1982; 12(5):403-7. PubMed ID: 6958214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Terminal deoxynucleotidyl transferase in acute leukemias by direct immunofluorescence.
    Nair CN; Gothoskar BP; Gladstone B; Badrinath Y; Chhajlani V; Karnik M; Nerurkar A; Damle SR; Redkar SL; Gopal R
    Neoplasma; 1987; 34(3):305-11. PubMed ID: 3302737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Terminal deoxynucleotidyl transferase activity in neoplastic and nonneoplastic hematopoietic cells.
    Bearman RM; Winberg CD; Maslow WC; Racklin B; Carlson F; Nathwani BN; Kim H; Diamond LW; Fallis B; Rappaport H
    Am J Clin Pathol; 1981 Jun; 75(6):794-802. PubMed ID: 7020399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.